EP Patent

EP3368089B1 — Nanoparticle formulations for delivery of nucleic acid complexes

Assigned to Translate Bio MA Inc · Expires 2025-11-05 · 1y expired

What this patent protects

Patent listed against Amondys 45.

Drugs covered by this patent

Amondys 45 (CASIMERSEN) · Sarepta

Patent Metadata

Patent number: EP3368089B1
Jurisdiction: EP
Classification: —
Expires: 2025-11-05
Drug substance claim: No
Drug product claim: No
Assignee: Translate Bio MA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.